Rheumatoid Arthritis
sheila RHEUMarampa
5 years ago
This study shows that serum anti-PAD4, anti-PAD3/4XR abs are highly specific for RA-ILD and assoc'd w/ better lung function in RA-UIP.
Small patient sample. Potential prognostic biomarker? @RheumNow #ACR20 abs1200 https://t.co/f5VFjJhVXF
Saturday was the day 2 with many posters and live sessions at the 2020 Virtual ACR/ARP meeting. Here are a few of my highlights from day two:
Richard Conway RichardPAConway
5 years ago
Dr Lee reports on risk of melanoma and NMSC risk in RA in cohort study using propensity score matching. No difference in risk between MTX and HCQ overall. Increase BCC in MTX (HR 1.32) but less SCC (HR 0.77) @rheumnow #ACR20 Abstr#1001 https://t.co/LDWgfGK9LS
David Liew drdavidliew
5 years ago
Nintedanib in rheum ILD (RA/SSc/CTD)
I appreciate the volumes might not seem like much, but:
- in first 1y Rx 20% more are spared a FVC decline>10%
- biggest diff in UIP-like pattern
With the right patient selection, nintedanib does have its place!
#ACR20 ABST1048/1049 @RheumNow https://t.co/jGZdR84bBU
Subclinical Synovitis: Dr Eric Dein
Dr. Eric Dein reviews abstract #0481 presented at the 2020 ACR annual meeting, and reviews the Twitter poll he posted on whether clinicians would start DMARDs in this scenario.
Significance of ANA+ in Managing RA: Dr Eric Dein
Dr. Eric Dein reviews abstract #0755 presented at the ACR annual meeting.
alexa meara lexmeara
5 years ago
Great thoughts-how do we define seronegative RA as well? more studies like this are needed for patient centered medicine! @ACRheum @RheumNow @OSUWexMed #ACR20 https://t.co/7fUO70t09u
HCQ and QTc in RA and SLE Patients: Dr. Kathryn Dao
Dr. Kathryn Dao reviews abstract #0431 presented at the 2020 ACR annual meeting.
Richard Conway RichardPAConway
5 years ago
Watch my video discussing the SEAM-RA trial of treatment reduction in RA patients in remission on @rheumnow #ACR20 https://t.co/YDfBafBdRs
Lifestyle, Clinical Risk Factors for RA-ILD: Dr. Sheila Reyes
Dr. Sheila Reyes reviews abstract #1198 presented at the 2020 ACR annual meeting.
Peter Nash drpnash
5 years ago
Factors Associated to Clinical and Radiographic Disease Progression in Patients with Early RA and First-degree Relatives: A 1-year Follow-up https://t.co/GWboXit6m1 #RA #firstdegreerelatives obesity and periodontal disease drive risk - both preventable
Meral K. El Ramahi, MD MeralElRamahiMD
5 years ago
So excited to check out RheumNow’s ACR Mid-Meeting Recap live right now with Dr. Jack Cush (@rheumnow), Dr. Arthur Kavanaugh, Dr. Michale Pillinger, and Dr. Bella Mehta! #ACR20
Peter Nash drpnash
5 years ago
Minimum Clinically Important Improvement in Patients with Rheumatoid Arthritis Associates with Gut Microbiome https://t.co/D3ILR57gXY #RA #microbiome that microbiome again
Peter Nash drpnash
5 years ago
Time to Discontinuation of Tofacitinib and TNF Inhibitors in Rheumatoid Arthritis Patients with and Without Methotrexate: Real World Results from a Rheumatoid Arthritis Cohort https://t.co/ZzhE0J7dOX #TOFA #TNFi TNFi does better with MTX Tofa less necessary
Impact of Exercise on Sleep in RA: Dr. Kathryn Dao
Dr. Kathryn Dao discusses abstract #0134 presented Friday at the 2020 ACR annual meeting.
Poster Hall